Opportunity Information: Apply for CDC RFA GH16 1641
Apply for CDC RFA GH16 1641
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Feb 07, 2016 and posted on Feb 07, 2016.
- Applicants must submit their applications by Apr 07, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,292,104.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. Centers for Disease Control and Prevention (CDC) funding announcement focused on improving Namibia's ability to prevent, detect, and manage HIV and related infections through stronger laboratory and surveillance systems. Issued under PEPFAR, it is designed to support Namibia's broader epidemic control goals by ensuring the country has reliable, high-quality diagnostic and monitoring services that directly inform patient care and public health decision-making.
At its core, the program aims to strengthen community-based HIV/AIDS prevention, care, and treatment efforts by improving the laboratory backbone that makes those services effective. The grantee is expected to help enhance national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB). This includes building or improving systems that track disease burden and trends, support timely detection of cases, and generate data that can guide where prevention and treatment resources should be targeted. In practice, better surveillance typically depends on consistent specimen collection and transport, standardized testing practices, dependable reporting channels, and stronger links between laboratories, clinics, and public health authorities.
A major emphasis of the opportunity is expanding Namibia's capacity to provide quality diagnostic services for HIV, STIs, and TB, along with other conditions connected to HIV infection and transmission. That means supporting laboratory services that clinicians rely on to diagnose infections accurately and quickly, confirm cases, and monitor patients over time. The opportunity explicitly highlights laboratory monitoring of antiretroviral (ARV) treatment outcomes and related diagnostics, which points to strengthening testing that helps determine whether treatment is working and whether patients are achieving the desired clinical results. Strong ARV monitoring capacity is essential for identifying treatment failure, guiding regimen changes, and protecting long-term health outcomes while also reducing onward transmission.
The award is structured as a cooperative agreement, which generally indicates substantial involvement from the CDC in planning, technical support, and oversight, rather than a fully hands-off grant. The funding instrument and activity category are public health oriented, aligning with CDC's role in laboratory systems, surveillance, and epidemiology. The program is listed under CFDA 93.067, a category associated with global health activities, and is administered by HHS-CDC-CGH (CDC's Center for Global Health), reinforcing that it is part of a broader international HIV/TB response framework under PEPFAR.
Operationally, the funding announcement anticipates a single award with an award ceiling of $2,292,104, suggesting one primary implementer would be selected to lead or coordinate this work at a national level, likely in close collaboration with the Namibian Institute of Pathology (NIP) and relevant national stakeholders. The opportunity was posted on February 7, 2016, created the same day, and had an application closing date of April 7, 2016. Eligibility is described broadly as "Others" with additional eligibility details referenced outside the provided excerpt, which typically signals that the applicant pool could include certain types of organizations that meet specific criteria laid out in the full announcement.
Overall, the opportunity is best understood as a targeted investment in the diagnostic and surveillance infrastructure needed for epidemic control in Namibia. By improving laboratory quality, expanding diagnostic and monitoring capacity for HIV/STI/TB, and strengthening national surveillance systems, the program supports both individual patient outcomes (through better diagnosis and ARV monitoring) and population-level impact (through data-driven public health action and more effective targeting of prevention and treatment services).
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Strengthening HIV/AIDS, STI and TB Laboratory Services in the Namibian Institute of Pathology (NIP) for Epidemic Control in Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which U.S. agency is offering this funding?
The funding announcement is issued by the U.S. Centers for Disease Control and Prevention (CDC).
What program framework is this opportunity part of?
This opportunity is issued under the President's Emergency Plan for AIDS Relief (PEPFAR).
What is the primary purpose of the grant?
The primary purpose is to strengthen Namibia's ability to prevent, detect, and manage HIV and related infections by improving laboratory and surveillance systems, so that diagnostic and monitoring services are reliable, high-quality, and useful for patient care and public health decision-making.
What country and institution are central to the project?
The work is focused in Namibia and specifically emphasizes strengthening laboratory services in the Namibian Institute of Pathology (NIP).
Which diseases and conditions does the opportunity focus on?
The announcement focuses on HIV/AIDS, sexually transmitted infections (STIs), and tuberculosis (TB), along with other conditions connected to HIV infection and transmission.
How does this grant connect laboratory services to epidemic control?
The opportunity aims to strengthen the laboratory backbone that makes community-based HIV prevention, care, and treatment effective. By improving diagnostic quality and expanding surveillance, laboratory results can better inform clinical decisions and public health targeting of prevention and treatment resources.
What types of activities are expected related to surveillance?
The grantee is expected to help enhance national surveillance for HIV infection, STIs, and TB. This includes improving systems that track disease burden and trends, support timely detection of cases, and generate data to guide where prevention and treatment resources should be targeted.
What practical elements are mentioned as important for better surveillance?
The description notes that better surveillance typically depends on consistent specimen collection and transport, standardized testing practices, dependable reporting channels, and stronger links between laboratories, clinics, and public health authorities.
What is meant by expanding "quality diagnostic services" in this opportunity?
It refers to strengthening laboratory services clinicians rely on to diagnose infections accurately and quickly, confirm cases, and monitor patients over time for HIV, STIs, TB, and related conditions.
Does the opportunity include monitoring of HIV treatment outcomes?
Yes. The announcement explicitly highlights laboratory monitoring of antiretroviral (ARV) treatment outcomes and related diagnostics.
Why is ARV treatment monitoring emphasized?
Strong ARV monitoring capacity is described as essential for identifying treatment failure, guiding regimen changes, protecting long-term health outcomes, and reducing onward transmission.
What type of award mechanism is used for this funding?
The award is structured as a cooperative agreement.
What does a cooperative agreement imply about CDC involvement?
Based on the description provided, a cooperative agreement generally indicates substantial CDC involvement in planning, technical support, and oversight rather than a fully hands-off grant.
What is the program classification or CFDA number listed?
The opportunity is listed under CFDA 93.067.
Which part of CDC administers the opportunity?
It is administered by HHS-CDC-CGH (CDC's Center for Global Health).
How many awards are anticipated?
The announcement anticipates a single award.
What is the maximum funding amount available (award ceiling)?
The award ceiling is $2,292,104.
What does a single award suggest about implementation?
Based on the description, it suggests one primary implementer would be selected to lead or coordinate the work at a national level, likely in close collaboration with NIP and relevant national stakeholders.
When was the opportunity posted?
The opportunity was posted on February 7, 2016 (and created the same day).
What was the application closing date?
The application closing date was April 7, 2016.
What is the stated eligibility category?
Eligibility is described broadly as "Others," with additional eligibility details referenced outside the provided excerpt.
What does "Others" eligibility indicate in this context?
It typically signals that the applicant pool could include certain types of organizations that meet specific criteria laid out in the full announcement, but those specific criteria are not included in the information provided here.
What are the main expected outcomes of this investment?
The opportunity is described as a targeted investment in diagnostic and surveillance infrastructure. Expected outcomes include improved laboratory quality, expanded diagnostic and ARV monitoring capacity, stronger national surveillance systems, better individual patient outcomes through improved diagnosis and monitoring, and population-level impact through data-driven public health action and more effective targeting of services.
How does this opportunity support both clinical care and public health decision-making?
It supports clinical care by improving accurate diagnosis, case confirmation, and ongoing monitoring (including ARV outcomes), and supports public health decision-making by strengthening surveillance systems that produce timely, reliable data on disease burden and trends.
Browse more opportunities from the same agency: HHS-CDC-CGH
Browse more opportunities from the same category: Health
Next opportunity: Supporting the Caribbean Public Health Agency Research, Policy Development and Evaluation Unit (REPDU) to build/strengthen Strategic Information capacity in Caribbean countries under the President's Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Strengthening Public Health Capacity and Strategic Information Systems through Cooperation and Support Services from the Joint United Nations Programme on HIV/AIDS (UNAIDS) under the President's Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1641
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1641) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting the Caribbean Public Health Agency Research, Policy Development and Evaluation Unit (REPDU) to build/strengthen Strategic Information capacity in Caribbean countries under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1611 Funding Number: CDC RFA GH16 1611 Agency: HHS-CDC-CGH Category: Health Funding Amount: $500,000 |
| Supporting the National School of Public Health (SPH) to Strengthen Human Resources for Health (HRH) in HIV Care and Treatment and Epidemiology in Angola under the President's Emergency Plan for Aids Relief (PEPFAR) Apply for CDC RFA GH16 1605 Funding Number: CDC RFA GH16 1605 Agency: HHS-CDC-CGH Category: Health Funding Amount: $200,000 |
| Strategic Prevention Framework - Partnerships for Success (SPF-PFS) Apply for SP 16 003 Funding Number: SP 16 003 Agency: HHS-SAMHS Category: Health Funding Amount: $1,230,000 |
| Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT1) Apply for RFA RM 16 002 Funding Number: RFA RM 16 002 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Sudden Death in the Young (SDY) Registry Apply for CDC RFA DP14 140303CONT16 Funding Number: CDC RFA DP14 140303CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2) Apply for RFA RM 16 003 Funding Number: RFA RM 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Reducing Nosocomial and Community-Acquired Tuberculosis by Strengthening the Capacity of the South Africa Department of Health to Improve Implementation of Infection Control and Waste Management at all Levels of the Health System under PEPFAR Apply for CDC RFA GH16 1644 Funding Number: CDC RFA GH16 1644 Agency: HHS-CDC-CGH Category: Health Funding Amount: $2,000,000 |
| Provision of HIV/AIDS-related Strategic Information and Laboratory Support and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1604 Funding Number: CDC RFA GH16 1604 Agency: HHS-CDC-CGH Category: Health Funding Amount: $850,000 |
| Supporting the Implementation, Expansion, Sustainability, and Ownership of High Quality HIV Services in Siaya County in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1691 Funding Number: CDC RFA GH16 1691 Agency: HHS-CDC-CGH Category: Health Funding Amount: $3,000,000 |
| Telehealth Network Grant Program Apply for HRSA 16 012 Funding Number: HRSA 16 012 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Service Area Competition – Additional Area (SAC-AA) – St. Paul (Island), Alaska Apply for HRSA 16 167 Funding Number: HRSA 16 167 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ebola Containment and Prevention Equipment Grant Apply for CDC RFA GH15 163302CONT16 Funding Number: CDC RFA GH15 163302CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rapid Response to Ebola Viral Disease in West Africa through Strengthening of Surveillance Systems and Disruption of Chain of Transmission Interventions Apply for CDC RFA GH15 162902CONT16 Funding Number: CDC RFA GH15 162902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Public Health Leader Fellowship Program (PHLFP) Apply for CDC RFA PS15 150802CONT16 Funding Number: CDC RFA PS15 150802CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| PPHF16: Immunization –Improving Immunization Rates and Enhancing Disease Prevention through Partnerships with Providers and National Organizations that focus on Public Health – Financed Solely by 2016 Prevention and Public Health Funds Apply for CDC RFA IP14 140503PPHF16 Funding Number: CDC RFA IP14 140503PPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening Applied Epidemiology and Sustainable International Public Health Capacity through the Field Epidemiology Training Programs, Center for Global Health Apply for CDC RFA GH15 161902CONT16 Funding Number: CDC RFA GH15 161902CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening South Africas Laboratory and Epidemiology Capacity to Detect and Respond to Zoonotic Disease Outbreaks, Center for Global Health Apply for CDC RFA GH15 162202CONT16 Funding Number: CDC RFA GH15 162202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| “PPHF 2016: OSTLTS Partnerships—Building Capacity of the Public Health System to Improve Population Health through National, Nonprofit Organizations—finanaced in part by the 2016 Prevention and Public Health Fund” Apply for CDC RFA OT13 130204PPHF16 Funding Number: CDC RFA OT13 130204PPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Promoting Population Health through Increased Capacity in Alcohol Epidemiology Apply for CDC RFA DP16 1608 Funding Number: CDC RFA DP16 1608 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $150,000 |
| Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) Apply for CDC RFA CE14 140203CONT16 Funding Number: CDC RFA CE14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1641", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.